Epstein-Barr virus-associated gastric carcinoma in Kazakhstan

被引:25
作者
Alipov, Gabit [2 ]
Nakayama, Toshiyuki [1 ]
Nakashima, Masahiro [2 ]
Wen, Chun-Yang [1 ]
Niino, Daisuke [1 ]
Kondo, Hisayoshi [3 ]
Pruglo, Yuri [4 ]
Sekine, Ichiro [1 ,2 ]
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Pathol, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Tissue & Histopathol Sect,Div Sci Data Registry, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Biostat Sect, Div Sci Data Registry,Atom Bomb Dis Inst, Nagasaki 8528523, Japan
[4] Semipalatinsk Med Acad, Dept Pathol, Semipalatinsk, Kazakhstan
关键词
Gastric carcinomas; Epstein-Barr virus; EBV-encoded small RNA-1;
D O I
10.3748/wjg.v11.i1.27
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the incidence of Epstein-Barr virus-associated gastric cancer (EBV-GC) in Kazakhstan and to compare it with that in Russia, Western and Asian countries in order to evaluate the significance of epidemiopathologic and ethnic factors. METHODS: In situ hybridization (ISH) of EBV-encoded small RNA-1 (EBER-1) was used to identify the presence of EBER-1 signal in 139 formalin-fixed and paraffin-embedded GC tissues from Kazakhstan. RESULTS: EBER-1 expression was observed in the nuclei of 10% of the cases of GC (14/139), but not in the surrounding normal mucosa. The incidence of the diffuse type of EBV-GC was significantly higher in Kazakhstan (14%, 13/91) than that of the intestinal type (2%, 1/48). Furthermore, the incidence was significantly higher in males (14%, 12/89) than in females (3.7%, 2/53) from all countries. The overall incidence of EBV-GC increased from 6.7% in Asian countries to 8.7% in Russia, 10.1% in Kazakhstan and 16% in Western countries. CONCLUSION: Geographical differences in the incidence of EBV-GC may reflect the epidemiologic factors and/or dietary habits independent of histological type and sex. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:27 / 30
页数:4
相关论文
共 39 条
[1]   Epstein-Barr virus in tumours [J].
Anagnostopoulos, I ;
Hummel, M .
HISTOPATHOLOGY, 1996, 29 (04) :297-315
[2]  
[Anonymous], 2003, CANC MORB MORT KAZ P
[3]   CHARACTERIZATION OF THE MAJOR EPSTEIN-BARR VIRUS-SPECIFIC RNA IN BURKITT LYMPHOMA-DERIVED CELLS [J].
ARRAND, JR ;
RYMO, L .
JOURNAL OF VIROLOGY, 1982, 41 (02) :376-389
[4]  
BOYLE MJ, 1991, BLOOD, V78, P3004
[5]  
Chang K L, 1992, Diagn Mol Pathol, V1, P246, DOI 10.1097/00019606-199203000-00037
[6]   PREVALENCE OF THE A-TYPE AND B-TYPE OF EPSTEIN-BARR-VIRUS DNA IN NASOPHARYNGEAL CARCINOMA BIOPSIES FROM SOUTHERN CHINA [J].
CHEN, XY ;
PEPPER, SD ;
ARRAND, JR .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :463-466
[7]   THE SMALL RNAS OF EPSTEIN-BARR-VIRUS [J].
CLEMENS, MJ .
MOLECULAR BIOLOGY REPORTS, 1993, 17 (02) :81-92
[8]   LYMPHOBLASTOID TRANSFORMATION AND PRESENCE OF HERPES-TYPE VIRAL PARTICLES IN A CHINESE NASOPHARYNGEAL TUMOUR CULTURED IN VITRO [J].
DETHE, G ;
AMBROSIONI, JC ;
HO, HC ;
KWAN, HC .
NATURE, 1969, 221 (5182) :770-+
[9]  
FUKAYAMA M, 1994, LAB INVEST, V71, P73
[10]  
Galetsky SA, 1997, INT J CANCER, V73, P786, DOI 10.1002/(SICI)1097-0215(19971210)73:6&lt